Skip to content

Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy

Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy: Phase 4 Prospective Multicenter Real Life Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06319924
Acronym
XIMEPEG-RL
Enrollment
601
Registered
2024-03-20
Start date
2020-02-01
Completion date
2022-09-15
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation Solution, Colonoscopy, Colorectal Cancer

Brief summary

Several randomised studies have shown that the addition of low-dose Simethicone to the bowel preparation was sufficient to reduce the presence of bubbles during colonoscopy. The aim of this study was to evaluate the efficacy and safety of a bowel preparation containing low-dose Simethicone on bubble formation. Patients and Methods This prospective, real-life, phase 4 study was conducted from February 2020 to May 2021, in five private endoscopy centres, among adult patients undergoing a colonoscopy. Clinical, endoscopic and histological parameters were collected on e-CRF. The primary endpoint was the measurement of bubble formation in the various colon segments.

Interventions

DRUGSimethicone combined with Macrogol 4000 (PEG)

bowel preparation product for colonoscopy as part of CRC screening

Sponsors

Hospital St. Joseph, Marseille, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years

Inclusion criteria

patients : * scheduled for colonoscopy as part of CRC screening, using the bowel preparation with fixed low-dose of simethicone combined with Macrogol 4000 (PEG) * aged 50-75 years, * with no family history of CRC or personal history of colon polyps but with a positive Faecal Immunochemical Test (FIT), with a family history of CRC or personal history of colon polyps, * requiring surveillance colonoscopy after 5 years if diagnosed with one or two tubular adenomas \<10 mm in diameter (low-risk group) or after 3 years if diagnosed with at least 3 adenomas or any adenoma at least 10 mm in diameter or with high-grade dysplasia, according to French recommendations during the study inclusion period.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Assess the quality of the bowel preparation assessed by Bubble scaleDuring procedure
Assess the quality of the bowel preparation assessed by Boston Bowel Preparation Scale (BBPS)During procedure

Secondary

MeasureTime frameDescription
Colonoscope removal timeimmediately post proceduretime spent by the endoscopist searching for polyps and adenomas (mn)
The frequency of adverse events (AEs)within 10 minutes post procedureincluding nausea, vomiting, abdominal bloating - and their severity,
volume of bowel preparation ingestedimmediately post procedurein ml
Caecal intubation rateimmediately post procedure.successful Caecal intubation

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026